Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Qianliexin capsules for chronic prostatitis
ChiCTR2200057560Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of qianliexin in chronic prostatitis (CP), sponsored by Beijing University of Chinese Medicine. Primary endpoints: NIH-Chronic Prostatitis Symptom Index response rate and NIH-Chronic Prostatitis Symptom Index total score. Started Aug 2021; status: recruiting.
02
Drugs
qianliexin
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR2200057560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057560.